NeoGenomics Stock (NASDAQ:NEO), Quotes and News Summary

Q: What sector and industry does NeoGenomics (NEO) operate in?

NeoGenomics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

NeoGenomics Stock (NASDAQ: NEO) stock price, news, charts, stock research, profile.

Open	$15.410
Close	-
Volume / Avg.	310.834K / 949.380K
Day Range	15.330 - 15.746
52 Wk Range	11.030 - 21.220
Market Cap	$1.980B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	7.88%
Days to Cover	10.12

Recent News

Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly dividend approximately 50% to 40 cents per share.

Avi Kapoor

Why Is Cancer Genetics Test-Focused NeoGenomics Stock Trading Higher Today?

NeoGenomics shines in Q4 2023 with an EPS turnaround to $0.03, beating estimates. Sales reach $155.55 million. CEO Chris Smith anticipates strong growth, guiding a positive fiscal 2024 outlook with an EPS forecast of $0.04.

Vandana Singh

Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Dec 23

Feb

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NeoGenomics (NEO) stock?

You can purchase shares of NeoGenomics (NASDAQ: NEO) through any online brokerage.

View our list of the best stock brokerages.

Who are NeoGenomics's (NEO) competitors?

Other companies in NeoGenomics’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Agiliti (NYSE:AGTI), Hims & Hers Health (NYSE:HIMS) and Privia Health Gr (NASDAQ:PRVA).

What is the target price for NeoGenomics (NEO) stock?

The latest price target for NeoGenomics (NASDAQ: NEO) was reported by BTIG on Thursday, May 2, 2024. The analyst firm set a price target for 21.00 expecting NEO to rise to within 12 months (a possible 36.81% upside). 26 analyst firms have reported ratings in the last year.

Current Stock Price for NeoGenomics (NEO)?

The stock price for NeoGenomics (NASDAQ: NEO) is $15.35 last updated Today at May 6, 2024 at 7:12 AM EDT.

Does NeoGenomics (NEO) pay a dividend?

There are no upcoming dividends for NeoGenomics.

When is NeoGenomics (NASDAQ:NEO) reporting earnings?

NeoGenomics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Is NeoGenomics (NEO) going to split?

There is no upcoming split for NeoGenomics.

What sector and industry does NeoGenomics (NEO) operate in?

NeoGenomics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-